Skip Navigation

   

List of Studies in the Chronic Kidney Disease Consortium Phase 1

Collaborators (study name + investigators)

Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation trial (ADVANCE): Mark Woodward, Toshiharu Ninomiya, John Chalmers, Stephen MacMahon

African American Study of Kidney Disease and Hypertension (AASK): Jackson Wright, Larry Appel, Tom Greene

Alberta Kidney Disease Network (AKDN): Marcello Tonelli, Brenda Hemmelgarn

Atherosclerosis Risk in Communities (ARIC): Josef Coresh, Brad C. Astor, Kunihiro Matsushita, Yaping Wang

Australian Diabetes, Obesity, and Lifestyle Study (AusDiab): Robert C. Atkins, Kevan R. Polkinghorne, Steven J. Chadban

Beaver Dam Chronic Kidney Disease Study (Beaver Dam): Anoop Shankar, Ronald Klein, Barbara EK Klein

Beijing Cohort Study (Beijing): HaiYan Wang, Fang Wang, Luxia Zhang, Lisheng Liu

British Columbia Chronic Kidney Disease (British Columbia CKD): Adeera Levin, Ognjenka Djurdjev

Cardiovascular Health Study (CHS): Michael Shlipak, Mark J. Sarnak, Ronit Katz, Linda F. Fried

The Cholesterol and Recurrent Events Trial (CARE): Marcello Tonelli, Frank Sacks Gary Curhan

COBRA Study (COBRA): Tazeen Jafar, Muhammad Islam, Juanita Hatcher, Neil Poulter, Nish Chaturvedi

Chronic Renal Impairment in Birmingham (CRIB): David C Wheeler, Martin J. Landray, John N Townend, Jonathan Emberson

ESTHER Study (ESTHER): Dietrich Rothenbacher, Hermann Brenner, Elke Raum, Wolfgang Koenig

Framingham Heart Study (Framingham): Caroline S. Fox, Shih-Jen Hwang, James B. Meigs

Grampian Chronic Kidney Disease (Grampian CKD): Laura E. Clark, Alison Macleod, Angharad Marks, Tariq Ali, Nicholas Fluck, Gordon Prescott

Gubbio Study (Gubbio): Massimo Cirillo

Kidney Early Evaluation Program (KEEP): Allan J. Collins, Suying Li and Shu-Cheng Chen

Kaiser Permanente Hawaii Cohort (KP Hawaii Cohort): Brian J. Lee

Kaiser Permanente Northwest: David H. Smith, Jessica R. Weinstein, Eric S. Johnson, Micah L. Thorp

Mild to Moderate Kidney Disease Study (MMKD): Florian Kronenberg, MD; Barbara Kollerits

Modification of Diet in Renal Disease Study (MDRD): Vandana Menon, Mark Sarnak, Tom Greene, Gerald Beck

Multi-Ethnic Study of Atherosclerosis (MESA): Michael Shlipak, Mark J. Sarnak, Ronit Katz, Linda F. Fried

Multifactorial Approach and Superior Treatment Efficacy in Renal Patients with the Aid of a Nurse Practicioner (MASTERPLAN): Jack F. Wetzels,P.J. Blankestijn, A.D. van Zuilen

MRC Study of assessment of older people (MRC Older People): Paul Roderick, Dorothea Nitsch, Astrid Fletcher, Christopher Bulpitt

Multiple Risk Factor Intervention Trial (MR-FIT): Areef Ishani, James Neaton, Ken Svendsen

NephroTest: Marc Froissart, Benedicte Stengel, Marie Metzger

Nord Trøndelag Health Study (HUNT): Stein Hallan, Stian Lydersen, Jostein Holmen

Ohasama Study (Ohasama): Takayoshi Ohkubo, Hirohito Metoki, Masaaki Nakayama, Masahiro Kikuya, Yutaka Imai

Okinawa Study (1983)/ Okinawa Study (1993)(OGHMA-OKID 83 and 93): Kunitoshi Iseki

Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study (ONTARGET): Johannes F.E. Mann, Salim Yusuf, Koon K. Teo, Peggy Gao

Pima Indian Study (Pima): Robert G Nelson, William C Knowler

Prevention of Renal and Vascular End-stage Disease Study (PREVEND): Ron T. Gansevoort, Paul E. de Jong, Marije van der Velde

Ramipril Efficacy in Nephropathy (REIN 1 and 2): Giuseppe Remuzzi, Piero Ruggenenti, Annalisa Perna

Rancho Bernardo Study (Rancho Bernardo): Simerjot Kaur Jassal, Elizabeth Barrett-Connor, Jaclyn Bergstrom

Reasons for Geographic And Racial Differences in Stroke Study (REGARDS): David G. Warnock, Paul Muntner, Suzanne Judd, William M. McClellan, Mary Cushman, George Howard, Leslie McClure

Reduction of Endpoints in Non-insulin Dependent Diabetes Mellitus with the Angiotensin II Antagonist Losartan (RENAAL): H.J. Lambers Heerspink, Barry Brenner, Dick de Zeeuw

Severance Cohort Study (Severance): Sun Ha Jee, Heejin Kimm, Ji Eun Yun

Steno Type 1 Diabetes Study (STENO): Peter Rossing, Hans-Henrik Parving

Taiwan MJ Cohort Study (Taiwan): Chi-Pang Wen, Sung-Feng Wen, Chwen-Keng Tsao, Min-Kuang Tsai

Telmisartan Randomised Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease Trial (TRANSCEND): Johannes F.E. Mann, Salim Yusuf, Koon K. Teo, Peggy Gao

Third US National Health and Nutrition Examination Survey (NHANES III): Brad Astor, Josef Coresh

Uppsala Longitudinal Study of Adult Men (ULSAM): Johan Ärnlöv

Zwolle Outpatient Diabetes project Integrating Available Care (ZODIAC): Henk J. Bilo, Hanneke Joosten, Nanno Kleefstra, K.H. Groenier

 

© 2015, Johns Hopkins University. All rights reserved.
Web policies, 615 N. Wolfe Street, Baltimore, MD 21205